aminopterin has been researched along with Lymphoma, T-Cell, Cutaneous in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Foss, FM; Girardi, M; Li, A; Parker, TL | 2 |
| Imataki, O; Kadowaki, N; Uchida, S; Uemura, M; Yokokura, S | 1 |
| Kerdel, FA; Maini, A; Styperek, AR | 1 |
| Wood, GS; Wu, J | 1 |
| Gilreath, JA; Halwani, AS; McPherson, JP; Sedillo, C; Vrontikis, A | 1 |
| Horwitz, SM | 1 |
| Bartlett, NL; Delioukina, ML; Duvic, M; Fisher, DC; Foss, F; Horwitz, SM; Kim, YH; Koutsoukos, T; Lechowicz, MJ; Myskowski, PL; O'Connor, OA; Saunders, ME; Shustov, AR; Zain, JM | 1 |
| Schmidt, C | 1 |
2 review(s) available for aminopterin and Lymphoma, T-Cell, Cutaneous
| Article | Year |
|---|---|
Methotrexate and Pralatrexate.
Topics: Aminopterin; Antimetabolites, Antineoplastic; Apoptosis; DNA Methylation; Epigenesis, Genetic; Folic Acid Antagonists; Humans; Lymphoma, T-Cell, Cutaneous; Methotrexate; S Phase; Skin Neoplasms | 2015 |
Novel therapies for cutaneous T-cell lymphomas.
Topics: Aminopterin; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Diphtheria Toxin; Folic Acid Antagonists; Histone Deacetylase Inhibitors; Humans; Interleukin-2; Lymphoma, T-Cell, Cutaneous; Photopheresis; Recombinant Fusion Proteins; Skin Neoplasms; Tetrahydronaphthalenes | 2008 |
1 trial(s) available for aminopterin and Lymphoma, T-Cell, Cutaneous
| Article | Year |
|---|---|
Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Antimetabolites, Antineoplastic; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Eruptions; Fatigue; Female; Gastrointestinal Diseases; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Mucositis; Neutropenia; Salvage Therapy; Skin Neoplasms; Thrombocytopenia | 2012 |
6 other study(ies) available for aminopterin and Lymphoma, T-Cell, Cutaneous
| Article | Year |
|---|---|
Clinical Activity of Pralatrexate in Patients With Cutaneous T-Cell Lymphoma Treated With Varying Doses of Pralatrexate.
Topics: Aminopterin; Dose-Response Relationship, Drug; Female; Folic Acid Antagonists; Follow-Up Studies; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Prognosis; Retrospective Studies; Skin Neoplasms | 2018 |
Small Primary Cutaneous γδT-Cell Lymphoma Lesions Successfully Treated With Pralatrexate.
Topics: Adult; Aminopterin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Cutaneous; Positron-Emission Tomography; Skin Neoplasms; Treatment Outcome | 2019 |
Effect of leucovorin administration on mucositis and skin reactions in patients with peripheral T-cell lymphoma or cutaneous T-cell lymphoma treated with pralatrexate.
Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Female; Humans; Leucovorin; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Mucositis; Neoplasm Staging; Premedication; Retrospective Studies; Skin Diseases; Treatment Outcome | 2019 |
Clinical remission of primary aggressive CD8+ cutaneous T-cell lymphoma after pralatrexate infusion.
Topics: Aminopterin; Biopsy, Needle; CD8-Positive T-Lymphocytes; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Immunohistochemistry; Infusions, Intravenous; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Skin Neoplasms; Time Factors; Treatment Outcome | 2014 |
Pralatrexate Monitoring Using a Commercially Available Methotrexate Assay to Avoid Potential Drug Interactions.
Topics: Aged; Aminopterin; Drug Interactions; Drug Monitoring; Folic Acid Antagonists; Furosemide; Humans; Infusions, Intravenous; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Pleural Effusion; Reagent Kits, Diagnostic; Skin Neoplasms; Sodium Potassium Chloride Symporter Inhibitors; Treatment Outcome | 2016 |
Cutaneous T-cell lymphoma's confounding nature.
Topics: Aged; Alemtuzumab; Aminopterin; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Brentuximab Vedotin; Delayed Diagnosis; Diagnosis, Differential; Humans; Immunoconjugates; Lymphoma, T-Cell, Cutaneous; Male; Mycosis Fungoides; Remission Induction; Sezary Syndrome; Stem Cell Transplantation; Tetrahydronaphthalenes; Transplantation, Homologous | 2012 |